Wall Street expects a year-over-year increase in earnings on higher revenues when Idexx Laboratories (IDXX) reports results for the quarter ended September 2025. While this widely-known consensus ...

Idexx Laboratories (IDXX) reported $1.11 billion in revenue for the quarter ended June 2025, representing a year-over-year increase of 10.6%. EPS of $3.63 for the same period compares to $2.44 a year ...

IDEXX Laboratories, Inc. IDXX is set to release third-quarter 2025 results on Nov. 3, before the opening bell. In the last reported quarter, the company posted adjusted earnings per share (EPS) of ...

WESTBROOK, Maine, Feb. 15, 2024 /PRNewswire/ -- IDEXX Laboratories, Inc. (IDXX), a global leader in pet healthcare innovation, announces the launch of Vello, a software solution that seamlessly ...

IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2025 fourth quarter and full year financial results for Monday, February 2, 2026 ...

IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and ...

IDEXX Laboratories IDXX has outperformed the market over the past 20 years by 4.25% on an annualized basis producing an average annual return of 12.73%. Currently, IDEXX Laboratories has a market ...

IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced the availability of ...

IDEXX Laboratories delivered good Q4 results, but guidance below long-term target growth rates and ongoing weakness in vet visit volumes drove a selloff. Q4 revenue grew 14% with standout performance ...